Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P21
Within normal range
vs 3Y Ago
-19.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -21.35% |
| Q3 2025 | -18.45% |
| Q2 2025 | -5.21% |
| Q1 2025 | -14.24% |
| Q4 2024 | -11.80% |
| Q3 2024 | -17.52% |
| Q2 2024 | -9.25% |
| Q1 2024 | 24.24% |
| Q4 2023 | -13.19% |
| Q3 2023 | -25.43% |
| Q2 2023 | -3.89% |
| Q1 2023 | -10.85% |
| Q4 2022 | 1.11% |
| Q3 2022 | 25.61% |
| Q2 2022 | -56.20% |
| Q1 2022 | -14.40% |
| Q4 2021 | 1.49% |
| Q3 2021 | -52.94% |
| Q2 2021 | 19.14% |
| Q1 2021 | 24.48% |
| Q4 2020 | -53.97% |
| Q3 2020 | -28.95% |
| Q2 2020 | 12.63% |
| Q1 2020 | -20.85% |
| Q4 2019 | 8.46% |
| Q3 2019 | 3.11% |
| Q2 2019 | 31.67% |
| Q1 2019 | -83.35% |
| Q4 2018 | -29.81% |
| Q3 2018 | 55.85% |
| Q2 2018 | 86.11% |
| Q1 2018 | -2975.55% |
| Q4 2017 | 85.43% |
| Q3 2017 | 7.71% |
| Q2 2017 | 16.62% |
| Q1 2017 | -6.05% |
| Q4 2016 | -9.15% |
| Q3 2016 | 7.37% |
| Q2 2016 | 7.85% |
| Q1 2016 | -6.09% |